A 38-year-old Indian woman presents with menorrhagia and dysmenorrhea for the past 18 months. She reports heavy menstrual bleeding lasting 7–8 days with passage of clots, and severe lower abdominal pain during menses. On examination, the uterus is firm, irregularly enlarged (approximately 12-week size), and non-tender. Hemoglobin is 9.2 g/dL. Transvaginal ultrasound shows multiple intramural and submucosal fibroids, the largest being 4 cm. She has completed her family and desires definitive treatment. Which of the following is the most appropriate management?

Explanation

## Clinical Context This patient has symptomatic uterine fibroids with menorrhagia causing anemia, completed family, and desire for definitive treatment. The uterus is markedly enlarged (12-week size) with multiple intramural and submucosal fibroids. ## Management Algorithm for Symptomatic Fibroids ```mermaid flowchart TD A[Symptomatic Uterine Fibroids]:::outcome --> B{Fertility desired?}:::decision B -->|Yes| C{Symptoms severe?}:::decision B -->|No| D{Uterus size & burden?}:::decision C -->|Mild-moderate| E[LNG-IUD, NSAIDs, Iron]:::action C -->|Severe| F[Myomectomy]:::action D -->|Small-moderate| G[Medical Mx: LNG-IUD, GnRH-a, Tranexamic acid]:::action D -->|Large/multiple| H[Hysterectomy]:::action E --> I[Reassess in 3-6 months]:::outcome F --> J[Preserve fertility]:::outcome G --> K[Symptom control]:::outcome H --> L[Definitive cure]:::outcome ``` ## Why Total Abdominal Hysterectomy is Correct **Key Point:** In a woman with completed family, severe menorrhagia causing anemia, and markedly enlarged uterus (12-week size) with multiple fibroids, hysterectomy is the gold-standard definitive treatment. **High-Yield:** Indications for hysterectomy in fibroid uterus: - Completed family - Severe, refractory menorrhagia with anemia - Uterus >12-week size - Multiple intramural/submucosal fibroids - Symptoms unresponsive to medical therapy **Clinical Pearl:** Hysterectomy offers 100% cure rate and eliminates risk of fibroid recurrence, unlike myomectomy (recurrence rate 15–30%). Given her anemia (Hb 9.2 g/dL) and desire for definitive treatment, medical options are suboptimal. ## Why Other Options Are Suboptimal | Option | Limitation | |--------|----------| | **Myomectomy + hormonal therapy** | Preserves fertility (not desired here); high recurrence; does not address large uterine size; prolonged recovery | | **LNG-IUD + iron** | Suitable for mild-moderate bleeding in women desiring fertility; insufficient for severe menorrhagia with anemia and large fibroid burden | | **GnRH agonist** | Temporary shrinkage (3–6 months); fibroids regrow after cessation; used as bridge therapy, not definitive; side effects (hypoestrogenism) limit long-term use | [cite:Jeffcoate's Principles of Gynaecology Ch 18]